# Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

> **NCT00989287** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 131 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GSK2340272A
- **BIOLOGICAL:** GSK2340269A

## Key facts

- **NCT ID:** NCT00989287
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-07
- **Primary completion:** 2009-10-09
- **Final completion:** 2010-10-26
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00989287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00989287, "Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00989287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*